Nature Reviews Nephrology

Article	Citations
Cellular senescence: the good, the bad and the unknown	397
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality	356
Pathophysiology of COVID-19-associated acute kidney injury	327
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors	316
Mitochondrial quality control in kidney injury and repair	267
Hypertension-induced cognitive impairment: from pathophysiology to public health	264
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease	213
The effect of HIF on metabolism and immunity	204
Epidemiology of haemodialysis outcomes	196
Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation	192
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	185
Cisplatin nephrotoxicity: new insights and therapeutic implications	185
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection	170
Trajectories of kidney function in diabetes: a clinicopathological update	156
The fibrogenic niche in kidney fibrosis: components and mechanisms	156
Nitric oxide signalling in kidney regulation and cardiometabolic health	146
Pathogenesis of autoimmune disease	136
Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative	123
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects	120
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function	119
Multi-omics integration in the age of million single-cell data	118
Sustainable Development Goals relevant to kidney health: an update on progress	114
Role of the cGAS–STING pathway in systemic and organ-specific diseases	111
Trained immunity — basic concepts and contributions to immunopathology	111
COVID-19 vaccination in kidney transplant recipients	110

Organ donation and transplantation: a multi-stakeholder call to action	110
Regulated cell death pathways in kidney disease	110
Therapeutic advances in COVID-19	103
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	101
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	99
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence	98
The gut microbiome and hypertension	97
Association of metabolic dysfunction-associated fatty liver disease with kidney disease	96
Extracellular vesicles in kidney disease	94
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations	93
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury	92
COVID-19 vaccines and kidney disease	89
Glomerular hyperfiltration	88
The genetics of kidney stone disease and nephrocalcinosis	86
The roles of tertiary lymphoid structures in chronic diseases	86
Epidemiology of peritoneal dialysis outcomes	85
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics	84
Kidney and heart failure outcomes associated with SGLT2 inhibitor use	83
The COVID-19 pandemic: consequences for nephrology	83
Renal microvascular endothelial cell responses in sepsis-induced acute kidney injury	82
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease	80
Phenotypic diversity and metabolic specialization of renal endothelial cells	78
Advances in CRISPR therapeutics	78
Health inequities and the inappropriate use of race in nephrology	78
Pathophysiological mechanisms leading to muscle loss in chronic kidney disease	77
MicroRNAs in kidney injury and disease	77
Gasdermins and pyroptosis in the kidney	75
Circular RNAs in kidney disease and cancer	75
The role of immune cells and mediators in preeclampsia	75
Complosome — the intracellular complement system	74
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease	72
COVID-19 vaccine hesitancy	72
Membranous nephropathy: new pathogenic mechanisms and their clinical implications	69
Chronic kidney disease and the global public health agenda: an international consensus	65
Long COVID and kidney disease	65
The impact of excessive salt intake on human health	64
Therapeutic trials in adult FSGS: lessons learned and the road forward	63
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	62
Tackling AKI: prevention, timing of dialysis and follow-up	60
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease	60
Vaccination in patients with kidney failure: lessons from COVID-19	58
Key metalloproteinase-mediated pathways in the kidney	58
The Mesangial cell — the glomerular stromal cell	58
Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group	57
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease	57
The therapeutic potential of apelin in kidney disease	56
The evolving story of apolipoprotein L1 nephropathy: the end of the beginning	54
Progress in xenotransplantation: overcoming immune barriers	50
Conceptual advances and evolving terminology in acute kidney disease	49
Oxalate homeostasis	48

Experimental models of acute kidney injury for translational research	47
Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases	47
Mapping the human kidney using single-cell genomics	46
Kidney and epigenetic mechanisms of salt-sensitive hypertension	45
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	44
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice	43
The role of lysosomes in metabolic and autoimmune diseases	43
Oxidative stress and the role of redox signalling in chronic kidney disease	42
The nephropathy of sickle cell trait and sickle cell disease	41
Targeting immune cell metabolism in kidney diseases	41
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	38
Immunometabolic rewiring of tubular epithelial cells in kidney disease	38
Artificial intelligence-enabled decision support in nephrology	37
Mechanisms and consequences of sex differences in immune responses	36
Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases	36
Non-invasive molecular imaging of kidney diseases	35
The lymphatics in kidney health and disease	35
Activation and regulation of alloreactive T cell immunity in solid organ transplantation	35
Differences in the epidemiology, management and outcomes of kidney disease in men and women	34
Cardiac metabolic remodelling in chronic kidney disease	34
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury	34
The perils of misinformation: when health literacy goes awry	34
Ultrafiltration in critically ill patients treated with kidney replacement therapy	34
Unconventional T cells and kidney disease	34
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	33
Nephron overload as a therapeutic target to maximize kidney lifespan	33
The evolving complexity of the collecting duct renin–angiotensin system in hypertension	33
SGLT2 inhibitors may offer benefit beyond diabetes	32
Long COVID: long-term health outcomes and implications for policy and research	31
RNA-binding proteins and their role in kidney disease	28
Role of necroptosis in kidney health and disease	28
Inequities in kidney health and kidney care	27
The pathophysiology of distal renal tubular acidosis	26
Youth-onset type 2 diabetes mellitus: an urgent challenge	26
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants	26
Regulation of FGF23 production and phosphate metabolism by bone–kidney interactions	25
Biomimetic models of the glomerulus	25
Principles of human and mouse nephron development	25
Pathogenic cellular and molecular mediators in lupus nephritis	25
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	24
Continuing kidney care in conflicts	23
The role of complement in kidney disease	23
Sex differences in energy metabolism: natural selection, mechanisms and consequences	23
Diagnosis of cardiovascular disease in patients with chronic kidney disease	23
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	23
Stony the road we trod: towards racial justice in kidney care	22
Regulation of nephron progenitor cell lifespan and nephron endowment	21
Patient-centred clinical trial design	20
Sex differences in renal transporters: assessment and functional consequences	20
Kidney injury and disease in patients with haematological malignancies	20
The impact of intrauterine growth restriction and prematurity on nephron endowment	20
Opioids for chronic pain management in patients with dialysis-dependent kidney failure	19
Cell and gene therapy for kidney disease	18
Ferroptotic stress promotes the AKI to CKD transition	18
Managing climate change risks is imperative for human health	18
Immune cell behaviour and dynamics in the kidney — insights from in vivo imaging	18
Planar cell polarity pathway in kidney development, function and disease	18
The challenge of insomnia for patients on haemodialysis	17
The genetics and pathogenesis of CAKUT	17
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	17
Digital health and acute kidney injury: consensus report of the 27th Acute Disease Quality Initiative workgroup	16
Tissue-resident memory T cells in the urogenital tract	16
Expanding the therapy options for diabetic kidney disease	15
TRPM channels in health and disease	15
Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup	15
Designing acute kidney injury clinical trials	14
Inflammation and gut dysbiosis as drivers of CKD–MBD	14
COVID-19 vaccination in patients receiving dialysis	14
Kidney complications of parasitic diseases	14
Uropathogen and host responses in pyelonephritis	14
Regulatory T cells in autoimmune kidney diseases and transplantation	14
The role of claudins in homeostasis	13
Circulating non-coding RNAs in chronic kidney disease and its complications	13
The impact of the Russian–Ukrainian war for people with chronic diseases	13
Translating B cell immunology to the treatment of antibody-mediated allograft rejection	13
The realities of rationing in health care	12
Belzutifan: a novel therapy for von Hippel–Lindau disease	12
Disasters and kidney care: pitfalls and solutions	12
Aquaporin water channels: roles beyond renal water handling	12
An integrated approach towards a public health perspective on chronic kidney disease	10

Big Data in Nephrology	10
Pathological consequences of DNA damage in the kidney	10
Primary aldosteronism: molecular medicine meets public health	10
Staying on track to achieve racial justice in kidney care	9
Network medicine: an approach to complex kidney disease phenotypes	9
Determining lineage relationships in kidney development and disease	9
Supporting sexual and gender minority health-care workers	9
Role of biophysics and mechanobiology in podocyte physiology	9
Impact of persistent conflict and destabilizing events on dialysis care	8
Combination therapy for kidney disease in people with diabetes mellitus	8
Sirtuins in kidney health and disease	8
Educating primary healthcare providers about kidney disease	7
The impact of population ageing on the burden of chronic kidney disease	7
The immunoregulatory roles of non-haematopoietic cells in the kidney	7
Climate change-fuelled natural disasters and chronic kidney disease: a call for action	7
A pathway of osmotic stress-induced necroptosis	7
A new era of treatment for primary hyperoxaluria type 1	7
Advancing kidney health justice through gender-affirming care	7
Heat and health inequity: acting on determinants of health to promote heat justice	7
Potential SARS-CoV-2 kidney infection and paths to injury	7
Vascular damage in systemic lupus erythematosus	6
Physical activity and living well with kidney disease	6
Intersectionality as a lens for achieving kidney health justice	6
Kidney health in the context of economic development	6
Removal of race from estimation of kidney function	6
Long-term health outcomes associated with hydration status	6
The importance of sex and gender in basic and clinical research	6
Bridging the gap of referral to nephrology care	6
Acute kidney injury in patients with burns	6
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens	6
Clinical versus research genomics in kidney disease	5
AURORA 1 reports efficacy of voclosporin in lupus nephritis	5
Salt substitution: opportunities and challenges for nephrology	5
Refugees with kidney disease: an increasing global challenge	5
Chronic cardiovascular–kidney disorder: a new conceptual framework	5
New insights into cognitive decline in chronic kidney disease	5
Podocyte-targeted therapies — progress and future directions	5
The COVID-19 pandemic: progress in nephrology	5
Kidneys control inter-organ homeostasis	5
Prioritizing the quality of life of older adults with kidney disease	5
SGLT2 inhibitors may prevent diabetes	5
Physiological principles underlying the kidney targeting of renal nanomedicines	5
Ensuring health equity for sexual and/or gender minority individuals	5
Evolutionary genetics and acclimatization in nephrology	5
Informing clinical decision making during a pandemic — a call for better preparedness	4
Kidney health equity for Indigenous Australians: an achievable goal	4
A model of pig-to-human kidney transplantation	4
The changing landscape of HIV-associated kidney disease	4
Progress towards solving the donor organ shortage	4
Risk of kidney disease after living kidney donation	4
Treatment of SLE with anti-CD19 CAR-T cells	4
Considerations in the care of transgender persons	4
Organ protection beyond glycaemic control with SGLT2 inhibitors	4
Interorgan communication networks in the kidney–lung axis	4
Metabolic alterations in hereditary and sporadic renal cell carcinoma	4
Clonal haematopoiesis, ageing and kidney disease	4
New and emerging therapies for diabetic kidney disease	4
COVID-19 vaccination in patients with immunity-mediated kidney disease	4
Targeting complement in ANCA-associated vasculitis: insights from ADVOCATE	4
Interferon blockade in lupus: effects on antiviral immunity	4
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	4
Transition from paediatric to adult-focused care: unresolved issues	4
Potential cardiorenal benefits of efpeglenatide in diabetes	4
MSC therapy for diabetic kidney disease and nephrotic syndrome	4
Advances in ANCA-associated vasculitis and lupus nephritis	4
Calcium signalling and transport in the kidney	4
The molecular genetics of AKI	3
Biomolecular condensates in kidney physiology and disease	3
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress	3
Patient health literacy: understanding barriers to improve outcomes	3
Paths to organ damage and risk factors in AKI	3
Kidney disease in Venezuela: the impact of a lingering humanitarian crisis	3
The cilia mechanosensation debate gets (bio)physical	3
Senolytics for kidney repair	3
Digital determinants of health: opportunities and risks amidst health inequities	3
Restrictive fluid therapy and high-dose vitamin C in sepsis	3
Delivering on the potential of measuring nephron number in the clinic	3
Targeted identification of risk and treatment of diabetic kidney disease	3
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA	3
A new era in the science and care of kidney diseases	3
The multifaceted links between hearing loss and chronic kidney disease	3
Hope for resistant hypertension through BrigHTN and PRECISION	3
Including sexual orientation and gender identity data to advance nephrology care	3
DPEP1 mediates neutrophil and monocyte influx	3
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	3
Sexual orientation and gender identity in organ and tissue donation and transplantation	2
Daprodustat for anaemia in CKD	2
Kidney disease as a medical complication of eating disorders	2
Use of convalescent plasma in the treatment of COVID-19	2
Menopause and chronic kidney disease	2
A call for civic engagement	2
Electronic patient-reported outcomes in chronic kidney disease	2
Sleep disorders in chronic kidney disease	2
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes	2
Applications of SGLT2 inhibitors beyond glycaemic control	2